Orbimed Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed Advisors LLC
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions
Manager:
Search and click to pin securities to the top
Page 2 of 6
CYTOKINETICS INC
Shares:
1509205(-4.7%)
Value:
$60.7B(-18.6%)
CG Oncology, Inc.
Shares:
2471994(+72.7%)
Value:
$60.5B(+47.5%)
ArriVent BioPharma, Inc.
Shares:
3027328(+0.0%)
Value:
$56.0B(-30.6%)
Avidity Biosciences, Inc.
Shares:
1812886(+62.9%)
Value:
$53.5B(+65.4%)
SI-BONE, Inc.
Shares:
3442853(+0.0%)
Value:
$48.3B(+0.1%)
Axsome Therapeutics, Inc.
Shares:
386700
Value:
$45.1B
Compass Therapeutics, Inc.
Shares:
22362850(+0.0%)
Value:
$42.5B(+31.0%)
NeuroPace Inc
Shares:
3406335(+0.0%)
Value:
$41.9B(+9.8%)
829401108
Shares:
3704959
Value:
$38.8B
Upstream Bio, Inc.
Shares:
5693589(+0.0%)
Value:
$34.8B(-62.8%)
Xtant Medical Holdings, Inc.
Shares:
73114592(+0.0%)
Value:
$34.4B(+6.1%)
Tarsus Pharmaceuticals, Inc.
Shares:
653743
Value:
$33.6B
Crinetics Pharmaceuticals, Inc.
Shares:
999000(+0.0%)
Value:
$33.5B(-34.4%)
Xenon Pharmaceuticals Inc.
Shares:
947877(+0.0%)
Value:
$31.8B(-14.4%)
Apellis Pharmaceuticals, Inc.
Shares:
1432300
Value:
$31.3B
MBX Biosciences, Inc.
Shares:
4002887(+5.0%)
Value:
$29.5B(-58.0%)
EXACT SCIENCES CORP
Shares:
679816(+0.0%)
Value:
$29.4B(-22.9%)
GILEAD SCIENCES, INC.
Shares:
197500(-19.6%)
Value:
$22.1B(-2.5%)
Corvus Pharmaceuticals, Inc.
Shares:
6943654(+0.0%)
Value:
$22.1B(-40.6%)
Terns Pharmaceuticals, Inc.
Shares:
7562971(+0.0%)
Value:
$20.9B(-50.2%)